Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John T Isaacs

Showing results (11-20 of 134) with videos related to

Pageof 14
Sort By:
Nature Medicine|January 2, 2004
Androgen receptor outwits prostate cancer drugsJohn T Isaacs, William B Isaacs
Nature Reviews. Urology|September 15, 2018
Mesenchymal stem cells and the embryonic reawakening theory of BPHW Nathaniel Brennen, John T Isaacs
The Prostate|January 27, 2004
Development of prostate cancer treatment: the good newsSamuel R Denmeade, John T Isaacs
Cancer Research|September 3, 2004
Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cellsAarti R Uzgare, John T Isaacs
The Prostate|July 8, 2010
Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancerSamuel R Denmeade, John T Isaacs
Cancer Biology & Therapy|January 22, 2005
The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancerSamuel R Denmeade, John T Isaacs
The International Journal of Biochemistry & Cell Biology|February 8, 2005
Prostate cancer: potential targets of anti-proliferative and apoptotic signaling pathwaysAarti R Uzgare, John T Isaacs
Nature Reviews. Cancer|June 5, 2002
A history of prostate cancer treatmentSamuel R Denmeade, John T Isaacs
The Prostate|November 11, 2008
The alchemy of Jargon: etymologies of urologic neologisms: number 1--introduction to the seriesLochlan F Shelfer, John T Isaacs
The Prostate|March 26, 2018
The what, when, and why of human prostate cancer xenograftsW Nathaniel Brennen, John T Isaacs
Pageof 14

Showing results (11-20 of 134) with videos related to

Sort By:
Pageof 14
Nature Medicine|January 2, 2004
Androgen receptor outwits prostate cancer drugsJohn T Isaacs, William B Isaacs
Nature Reviews. Urology|September 15, 2018
Mesenchymal stem cells and the embryonic reawakening theory of BPHW Nathaniel Brennen, John T Isaacs
The Prostate|January 27, 2004
Development of prostate cancer treatment: the good newsSamuel R Denmeade, John T Isaacs
Cancer Research|September 3, 2004
Enhanced redundancy in Akt and mitogen-activated protein kinase-induced survival of malignant versus normal prostate epithelial cellsAarti R Uzgare, John T Isaacs
The Prostate|July 8, 2010
Bipolar androgen therapy: the rationale for rapid cycling of supraphysiologic androgen/ablation in men with castration resistant prostate cancerSamuel R Denmeade, John T Isaacs
Cancer Biology & Therapy|January 22, 2005
The SERCA pump as a therapeutic target: making a "smart bomb" for prostate cancerSamuel R Denmeade, John T Isaacs
The International Journal of Biochemistry & Cell Biology|February 8, 2005
Prostate cancer: potential targets of anti-proliferative and apoptotic signaling pathwaysAarti R Uzgare, John T Isaacs
Nature Reviews. Cancer|June 5, 2002
A history of prostate cancer treatmentSamuel R Denmeade, John T Isaacs
The Prostate|November 11, 2008
The alchemy of Jargon: etymologies of urologic neologisms: number 1--introduction to the seriesLochlan F Shelfer, John T Isaacs
The Prostate|March 26, 2018
The what, when, and why of human prostate cancer xenograftsW Nathaniel Brennen, John T Isaacs
Pageof 14